120 followers
9,413 followers
A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer Read it here: https://t.co/KIrJmh8VzR
906 followers
New article: A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer https://t.co/tBUPVAYZHn #breastcancer #oncology https://t.co/8hiV5BWaiF